James D. Birmingham - Publications

Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype.

Journal: ACR open rheumatology

Published: September 25, 2025

Emergent high fatality lung disease in systemic juvenile arthritis.

Journal: Annals of the rheumatic diseases

Published: July 17, 2019

Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: June 08, 2017

High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.

Journal: Pediatric rheumatology online journal

Published: April 28, 2014

Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.

Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

Published: March 04, 2014

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 31, 2013

Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug.

Journal: BMC medical informatics and decision making

Published: December 17, 2012